PubMed · 6820889
[Experimental study on local immunochemotherapy].
Abstract
The purposes of this work were twofold: firstly to determine whether intratumor chemoimmunotherapy was more effective than either treatment alone or systemic therapy and; secondly to study how the intratumor therapy affected on the development of the tumor-specific immunity. Inbred male C3H/He mice and mouse ascited hepatoma 134 (MH 134) of C3H origin were used as host-tumor system. Mitomycin C was used as the chemotherapeutic agent and BCG as the immunopotentiating agent. Intratumor treatment of MMC + BCG led to complete cure in 85 percent of the mice. The lymph node metastases were markedly inhibited in the group treated with MMC + BCG compared to the groups treated with MMC alone or BCG alone. The growth of rechallenged tumor was investigated; 79% of mice treated with MMC + BCG were immune to rechallenge, whereas 57% of mice treated with BCG alone. The number of PFC and DTH against SRBC of the mice treated with MMC intraperitoneally significantly decreased compared to that treated with MMC intratumorally.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M Kasuga, M Sakita, T Yamane, T Torii, H Imai, N Kageyama, Y Fujita, S Majima. 1982. [Experimental study on local immunochemotherapy].. https://pubmed.ncbi.nlm.nih.gov/6820889/
Cite the original work for its findings. Save a collection to share your selection of sources.